Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-014214
Filing Date
2024-12-23
Accepted
2024-12-23 14:36:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29675
2 filename2.txt TEXT-EXTRACT 3406
  Complete submission text file 0000000000-24-014214.txt   45040
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filed for) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 005-88023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)